A5086176049- Parkinson's Disease Mechanisms and Treatments
- Amyotrophic Lateral Sclerosis Research
- Neurological diseases and metabolism
- Lymphoma Diagnosis and Treatment
- Eosinophilic Disorders and Syndromes
- Botulinum Toxin and Related Neurological Disorders
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Genomics and Rare Diseases
- Pain Mechanisms and Treatments
- Dermatological and Skeletal Disorders
- Genetic Syndromes and Imprinting
- Blood Coagulation and Thrombosis Mechanisms
- Mesenchymal stem cell research
- Tracheal and airway disorders
- Cholinesterase and Neurodegenerative Diseases
- Myasthenia Gravis and Thymoma
- Extracellular vesicles in disease
- Neurogenetic and Muscular Disorders Research
- Medical and Biological Sciences
- Complement system in diseases
- Otitis Media and Relapsing Polychondritis
- Chronic Lymphocytic Leukemia Research
- Biomedical Ethics and Regulation
- Peripheral Neuropathies and Disorders
- Neurological disorders and treatments
Université de Limoges
2023
Centre Hospitalier Universitaire de Limoges
2006-2020
Hôpital Dupuytren
2004-2015
Human-adipose-tissue-derived mesenchymal stromal cells (AD-MSCs) are currently being tested as autologous-cell-based therapies for use in tissue healing and regeneration. Recent studies have also demonstrated that AD-MSC-derived exosomes contribute to repair peripheral nerve Subcutaneous abdominal adipose (AAT) is divided into two layers: the superficial layer (sAAT) deep (dAAT). However, it unclear whether there particular characteristics of each terms AD-MSC regenerative potential. Using...